{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T05:07:06Z","timestamp":1789103226426,"version":"build-2803163510"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Coronavirus disease 2019 (COVID-19), caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has posed a substantial global health challenge. Cognitive dysfunction is a prevalent and disabling manifestation of post-COVID-19 condition (PCC). This study aims to conduct a comprehensive bibliometric analysis of research on PCC and cognitive dysfunction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Publications on PCC and cognitive dysfunction published between 2021 and 2025 were retrieved from the Web of Science Core Collection (WoSCC) and Scopus. After screening according to inclusion criteria, Bibliometrix (R package), VOSviewer, and CiteSpace were employed for bibliometric and visualization analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>746 publications from the WoSCC and 1,117 publications from Scopus were included. Over the past 5\u202fyears, the number of publications on PCC-related cognitive dysfunction has exhibited a gradual upward trend. The United States showed the highest publication output, while the University of London demonstrated the highest number of publications among institutions in this network. The Journal of Clinical Medicine showed prominent publication and citation-related indicators in this field. Keyword analysis revealed three primary theme domains, including psychological factors, oxidative stress and neuroinflammation. Keyword burst detection revealed that blood\u2013brain barrier, choroid plexus, and endothelial cells represent emerging research frontiers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This bibliometric analysis systematically maps the global research landscape and evolving trends in PCC-related cognitive dysfunction. Our findings provide a broad overview of research development, collaboration patterns, and emerging topics, which may help generate hypotheses for future mechanistic investigations and clinical research.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneur.2026.1844317","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T04:35:17Z","timestamp":1789101317000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["A dual-database bibliometric analysis of post-COVID-19 condition and cognitive dysfunction (2021\u20132025)"],"prefix":"10.3389","volume":"17","author":[{"given":"Junlin","family":"Pu","sequence":"first","affiliation":[{"name":"School of Medical and Life Sciences, Chengdu University of Traditional Chinese Medicine","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Chen","sequence":"additional","affiliation":[{"name":"School of Medical and Life Sciences, Chengdu University of Traditional Chinese Medicine","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hangcheng","family":"Jiang","sequence":"additional","affiliation":[{"name":"School of Medical and Life Sciences, Chengdu University of Traditional Chinese Medicine","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Yang","sequence":"additional","affiliation":[{"name":"School of Medical and Life Sciences, Chengdu University of Traditional Chinese Medicine","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"key":"ref1","volume-title":"Coronavirus Disease (COVID-19)","year":"2025"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1007\/s00134-020-05985-9","article-title":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target","volume":"46","author":"Zhang","year":"2020","journal-title":"Intensive Care Med"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"16024","DOI":"10.1038\/npjamd.2016.24","article-title":"Deficiency of angiotensin-converting enzyme 2 causes deterioration of cognitive function","volume":"2","author":"Wang","year":"2016","journal-title":"NPJ Aging Mech Dis"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/s11064-018-2679-4","article-title":"ACE2 in brain physiology and pathophysiology: evidence from transgenic animal models","volume":"44","author":"Alenina","year":"2019","journal-title":"Neurochem Res"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"e20202135","DOI":"10.1084\/jem.20202135","article-title":"Neuroinvasion of SARS-CoV-2 in human and mouse brain","volume":"218","author":"Song","year":"2021","journal-title":"J Exp Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1159\/000536352","article-title":"Prevalence and trajectories of post-COVID-19 neurological manifestations: a systematic review and Meta-analysis","volume":"58","author":"Giussani","year":"2024","journal-title":"Neuroepidemiology"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.genhosppsych.2020.05.008","article-title":"Delirium in COVID-19: a case series and exploration of potential mechanisms for central nervous system involvement","volume":"65","author":"Beach","year":"2020","journal-title":"Gen Hosp Psychiatry"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1038\/s41591-022-02001-z","article-title":"Long-term neurologic outcomes of COVID-19","volume":"28","author":"Xu","year":"2022","journal-title":"Nat Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41398-024-02978-w","article-title":"Chronic post-COVID neuropsychiatric symptoms persisting beyond one year from infection: a case-control study and network analysis","volume":"14","author":"Chau","year":"2024","journal-title":"Transl Psychiatry"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jpsychires.2021.09.054","article-title":"Onset and frequency of depression in post-COVID-19 syndrome: a systematic review","volume":"144","author":"Renaud-Charest","year":"2021","journal-title":"J Psychiatr Res"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"100491","DOI":"10.1016\/j.bbih.2022.100491","article-title":"Neuropsychiatric sequelae of long COVID-19: pilot results from the COVID-19 neurological and molecular prospective cohort study in Georgia, USA","volume":"24","author":"Chen","year":"2022","journal-title":"Brain Behav Immun Health"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"6588","DOI":"10.1038\/s41467-023-41879-2","article-title":"Long-term health impacts of COVID-19 among 242,712 adults in England","volume":"14","author":"Atchison","year":"2023","journal-title":"Nat Commun"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41572-025-00674-7","article-title":"COVID-19-associated neurological and psychological manifestations","volume":"11","author":"Wilson","year":"2025","journal-title":"Nat Rev Dis Primers"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S2213-2600(23)00239-4","article-title":"Post-acute sequelae of COVID-19: understanding and addressing the burden of multisystem manifestations","volume":"11","author":"Parotto","year":"2023","journal-title":"Lancet Respir Med"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"3440","DOI":"10.3390\/jcm11123440","article-title":"Comprehensive clinical characterisation of brain fog in adults reporting long COVID symptoms","volume":"11","author":"Jennings","year":"2022","journal-title":"J Clin Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"9915","DOI":"10.1007\/s12035-023-03715-y","article-title":"Brain fog: a narrative review of the Most common mysterious cognitive disorder in COVID-19","volume":"61","author":"Aghajani","year":"2024","journal-title":"Mol Neurobiol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1111\/jnc.15985","article-title":"COVID-19 and the impact on Alzheimer's disease pathology","volume":"168","author":"Furman","year":"2024","journal-title":"J Neurochem"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3163\/1536-5050.103.4.013","article-title":"Bibliometrics basics","volume":"103","author":"Cooper","year":"2015","journal-title":"J Med Libr Assoc"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s40037-021-00695-4","article-title":"Bibliometrics: methods for studying academic publishing","volume":"11","author":"Ninkov","year":"2022","journal-title":"Perspect Med Educ"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"4213","DOI":"10.2147\/JMDH.S477256","article-title":"A bibliometric analysis of post-COVID-19 syndrome","volume":"17","author":"Liu","year":"2024","journal-title":"J Multidiscip Healthc"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"322","DOI":"10.4103\/bc.bc_107_24","article-title":"Exploring the link trend in the field of coronaviruses and cognitive impairment: a bibliometric analysis based on bibliometrix","volume":"11","author":"Cheng","year":"2025","journal-title":"Brain Circulation"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"118","DOI":"10.5530\/ijmedph.2023.3.19.48","article-title":"Post-COVID-19 impact on cognitive impairment: a bibliometric assessment of global literature during 2020\u201323","volume":"13","author":"Grover","year":"2023","journal-title":"Int J Med Public Health"},{"key":"ref24","article-title":"The Bibliometrix Online Platform","year":""},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1007\/s11192-017-2351-9","article-title":"A theoretical model of the relationship between the h-index and other simple citation indicators","volume":"111","author":"Bertoli-Barsotti","year":"2017","journal-title":"Scientometrics"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"16569","DOI":"10.1073\/pnas.0507655102","article-title":"An index to quantify an individual's scientific research output","volume":"102","author":"Hirsch","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s11192-009-0146-3","article-title":"Software survey: VOSviewer, a computer program for bibliometric mapping","volume":"84","author":"van Eck","year":"2010","journal-title":"Scientometrics"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.12688\/f1000research.171808.1","article-title":"A systematic literature review and bibliometric analysis of workplace coaching","volume":"14","author":"Jagadeeswari","year":"2025","journal-title":"F1000Res"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1016\/S1473-3099(21)00703-9","article-title":"A clinical case definition of post-COVID-19 condition by a Delphi consensus","volume":"22","author":"Soriano","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"101019","DOI":"10.1016\/j.eclinm.2021.101019","article-title":"Characterizing long COVID in an international cohort: 7 months of symptoms and their impact","volume":"38","author":"Davis","year":"2021","journal-title":"EClinicalMedicine"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"n1648","DOI":"10.1136\/bmj.n1648","article-title":"Long covid-mechanisms, risk factors, and management","volume":"374","author":"Crook","year":"2021","journal-title":"BMJ"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"317","DOI":"10.7507\/1001-5515.202101006","article-title":"Development and trends of real-world research based on bibliometric and knowledge map analysis","volume":"38","author":"Guo","year":"2021","journal-title":"J Biomed Eng"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s42466-024-00311-w","article-title":"Randomized controlled double-blind trial of methylprednisolone versus placebo in patients with post-COVID-19 syndrome and cognitive deficits: study protocol of the post-corona-virus immune treatment (PoCoVIT) trial","volume":"6","author":"Franke","year":"2024","journal-title":"Neurol Res Pract"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41593-025-01871-z","article-title":"Microglia dysfunction, neurovascular inflammation and focal neuropathologies are linked to IL-1- and IL-6-related systemic inflammation in COVID-19","volume":"28","author":"Fekete","year":"2025","journal-title":"Nat Neurosci"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1097\/MS9.0000000000000679","article-title":"IL1\u03b2, IL-6, and TNF-\u03b1 cytokines cooperate to modulate a complicated medical condition among COVID-19 patients: case-control study","volume":"85","author":"Faraj","year":"2023","journal-title":"Ann Med Surg (Lond)"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.bbi.2021.02.019","article-title":"Depression and interleukin-6 signaling: a mendelian randomization study","volume":"95","author":"Kelly","year":"2021","journal-title":"Brain Behav Immun"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12964-019-0356-0","article-title":"Response to IL-6 trans- and IL-6 classic signalling is determined by the ratio of the IL-6 receptor \u03b1 to gp130 expression: fusing experimental insights and dynamic modelling","volume":"17","author":"Reeh","year":"2019","journal-title":"Cell Commun Signal"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1742-2094-8-54","article-title":"Inhibition of interleukin-6 trans-signaling in the brain facilitates recovery from lipopolysaccharide-induced sickness behavior","volume":"8","author":"Burton","year":"2011","journal-title":"J Neuroinflammation"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"24335","DOI":"10.1038\/s41598-025-96608-0","article-title":"Cognitive impairment 2 years after mild to severe SARS-CoV-2 infection in a population-based study with matched-comparison groups","volume":"15","author":"Ara\u00fajo","year":"2025","journal-title":"Sci Rep"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"4130","DOI":"10.3390\/molecules30204130","article-title":"The role of probiotics and their postbiotic metabolites in post-COVID-19 syndrome","volume":"30","author":"Jach","year":"2025","journal-title":"Molecules"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"10120","DOI":"10.3390\/ijms262010120","article-title":"Microbiome and long COVID-19: current evidence and insights","volume":"26","author":"Caliman-Sturdza","year":"2025","journal-title":"Int J Mol Sci"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"e0321567","DOI":"10.1371\/journal.pone.0321567","article-title":"Efficacy of probiotics in patients with cognitive impairment: a systematic review and meta-analysis","volume":"20","author":"Ma","year":"2025","journal-title":"PLoS One"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12987-020-00230-3","article-title":"A blood-brain barrier overview on structure, function, impairment, and biomarkers of integrity","volume":"17","author":"Kadry","year":"2020","journal-title":"Fluids Barriers CNS"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1038\/s41593-021-00926-1","article-title":"The SARS-CoV-2 main protease M(pro) causes microvascular brain pathology by cleaving NEMO in brain endothelial cells","volume":"24","author":"Wenzel","year":"2021","journal-title":"Nat Neurosci"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.stemcr.2021.12.011","article-title":"The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2","volume":"17","author":"Krasemann","year":"2022","journal-title":"Stem Cell Reports"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"100046","DOI":"10.1016\/j.lana.2021.100046","article-title":"SARS-CoV-2 infection of the central nervous system in a 14-month-old child: a case report of a complete autopsy","volume":"2","author":"Gomes","year":"2021","journal-title":"Lancet Reg Health Am"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41586-021-03995-1","article-title":"Virus-induced senescence is a driver and therapeutic target in COVID-19","volume":"599","author":"Lee","year":"2021","journal-title":"Nature"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1038\/s43587-022-00321-w","article-title":"Severe COVID-19 is associated with molecular signatures of aging in the human brain","volume":"2","author":"Mavrikaki","year":"2022","journal-title":"Nat Aging"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.stem.2023.12.012","article-title":"SARS-CoV-2 infection causes dopaminergic neuron senescence","volume":"31","author":"Yang","year":"2024","journal-title":"Cell Stem Cell"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1844317\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T04:35:25Z","timestamp":1789101325000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1844317\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":49,"alternative-id":["10.3389\/fneur.2026.1844317"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2026.1844317","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]},"article-number":"1844317"}}